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Deep venous thrombosis (DVT) and its sequelae
affect millions of patients in the United States.1
Approximately 40% to 65% of involved limbs will
develop some degree of clinically evident post-
thrombotic syndrome.2,3 The economic and social
ramifications of caring for these patients with the
life-long sequelae of DVT are significant.4
Clinical data suggest that either thrombectomy
or thrombolysis early in the treatment of acute DVT
may improve long-term results.5 For example,
patients who undergo early spontaneous lysis during
standard anticoagulation therapy are less likely to
experience the development of valvular incompe-
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Purpose: Thrombolysis protects the structural and functional integrity of vein wall in an
experimental model of acute deep venous thrombosis (DVT) immediately after treat-
ment, but late sequelae have not been studied. We designed experiments to compare the
effects of thrombolysis and surgical thrombectomy at 4 weeks after the treatment of
DVT.
Methods: DVT was produced bilaterally in male mongrel dogs by proximal and distal
femoral vein ligation. Five dogs underwent sham operation. After 48 hours, the ligatures
were removed, and the thrombosis was treated with either Fogarty balloon catheter
thrombectomy (shear force, 60 g; n = 6) or catheter-directed urokinase infusion (4000
U/min for 90 minutes; n = 6). At 4 weeks, patency and valvular competence were deter-
mined by duplex ultrasound scanning. Thrombogenicity was studied by the measure-
ment of radiolabeled fibrin and platelet deposition. Veins were explanted and prepared
for histologic examination, scanning electron microscopy, and functional studies in
organ chambers.
Results: All veins were patent at 1 month. Recanalized thrombus was observed histolog-
ically in four (66%) thrombectomized veins, one (17%) thrombolyzed vein, and none of
the sham-operated veins (P = .04). Scanning electron microscopy demonstrated similar
luminal endothelial cell loss (11%-25%) in all three groups. Platelet and fibrin deposi-
tions were not different among groups. Valvular incompetence (reflux duration, >0.5
sec) did not differ significantly in the groups (thrombectomized veins, 2 of 12 (17%);
thrombolyzed veins, 0 of 12 (0%); P = NS). In organ chamber studies, endothelium-
dependent relaxations to calcium ionophore, but not adenosine diphosphate, were inhib-
ited by an antagonist of nitric oxide production after thrombectomy (P < .05, thrombec-
tomy vs sham- and thrombolysis-treated veins). All veins relaxed to exogenous nitric
oxide.
Conclusion: Both thrombectomy and thrombolysis restored patency and achieved similar
valvular competence. Surgical thrombectomy, however, resulted in more residual throm-
bus and contributed to changes in endothelium-mediated relaxations at 4 weeks.
Thrombolysis maintained both structural integrity and endothelial function. (J Vasc
Surg 2000;31:1193-205.)
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tence.6,7 Postthrombotic syndrome may develop in
up to 80% of patients who are treated with standard
anticoagulation therapy compared with only 36% of
those patients treated with thrombolytics.8 Venous
thrombectomy is another means of achieving early
clearance of thrombus, and some physicians advo-
cate it as the treatment of choice for iliofemoral
DVT.9,10 Plate et al9 demonstrated that 42% of
patients who were treated with iliofemoral venous
thrombectomy (with construction of a temporary
arteriovenous fistula) were asymptomatic at 6
months compared with only 7% of patients who
were treated with anticoagulation therapy alone.
Previous studies of acute arterial thrombosis have
demonstrated that thrombolysis with urokinase, but
not thrombectomy, preserved endothelium-depen-
dent relaxations and arterial smooth muscle contrac-
tility.11 In canine femoral veins subjected to acute
DVT, both thrombectomy and thrombolysis were
successful in the initial clearance of thrombus.12
However, immediately after treatment, relaxations
of thrombectomized segments to endothelium-
derived factors were reduced.12 Endothelium-
derived factors, such as nitric oxide, inhibit platelet
aggregation and the smooth muscle cell prolifera-
tion.13,14 Therefore alterations in responses to these
factors may contribute to the pathophysiologic con-
dition of recurrent DVT and postthrombotic syn-
drome. Understanding changes in nitric oxide–
mediated responses may assist in defining the opti-
mal therapy for DVT. Experiments were designed to
define the changes in valvular competence and
venous structure and function during the subacute
period after the treatment of DVT by either
thrombectomy or thrombolysis.
METHODS
Animal care was in compliance with the
“Principles of Laboratory Animal Care” formulated
by the National Society for Medical Research and
the “Guides for the Care and Use of Laboratory
Animals” prepared by the National Academy of
Sciences and published by the National Institutes of
Health (NIH Publication No. 86-23, revised 1985).
Male mongrel dogs (24–27 kg) were anesthetized
with intravenous sodium pentobarbital (30 mg/kg)
and hydrated with lactated Ringer’s solution (10
mL/kg/h). All animals were intubated to allow the
application of positive pressure during Valsalva
maneuvers.
With the use of the aseptic technique, bilateral
femoral veins were isolated from the inguinal liga-
ment to the popliteal vein; all side branches were li-
gated. The adventitia was dissected only in areas were
ligatures were placed. A distal side branch was cannu-
lated with a 14-gauge intravenous catheter to allow
retrograde flow during Valsalva maneuvers. The ani-
mals were placed in a 15-degree reverse
Trendelenburg position, and a Valsalva maneuver was
performed with sustained positive pressure (≥16 mm
Hg). Valvular incompetence was defined by reversal
of blood flow that lasted more than 0.5 seconds, as
determined by duplex image scanning (Apogee 800;
Advanced Technology Laboratories, Ambler, Pa).
Animals were randomized to one of three groups
(group 1, sham operated; group 2, thrombolysis;
group 3, thrombectomy). Groups 2 and 3 under-
went proximal and distal femoral vein ligation. The
wounds were closed in layers. After 48 hours, the
proximal and distal ligatures were removed. A distal
branch was cannulated with a 14-gauge intravenous
catheter that was directed towards the thrombus.
For thrombolysis, (group 2, n = 6) urokinase
(Abbokinase; Abbott Laboratories, North Chicago,
Ill) was continuously infused at 4000 U/min (0.43
mL/min) with the use of a Harvard pump (Harvard
Apparatus, Millis, Mass) for 90 minutes. Venous
patency was assessed every 30 minutes by duplex
ultrasound scanning. All vessels were patent by 90
minutes. For thrombectomy (group 3, n = 6), the
hub of a no. 4 Fogarty balloon catheter (Baxter
Healthcare, Santa Ana, Calif) was removed, and the
cut end was inserted through the 14-gauge intra-
venous catheter and passed proximally to a trans-
verse venotomy at the level of the inguinal ligament.
This avoided valvular damage from catheter passage.
The Fogarty catheter was cannulated with a 30-
gauge needle, inflated, and withdrawn once, at a
constant shear force of 60 gm of tension.11 The
venotomy was closed transversely with 6-0
polypropylene suture. Valvular competence was
again determined for both groups, and the animals
were allowed to recover.
After 4 weeks, animals in all groups were anes-
thetized, and the femoral veins were exposed over
their entire length. The popliteal vein was cannulat-
ed with a 14-gauge intravenous catheter, and valvu-
lar competence was again assessed. One femoral vein
was harvested for organ chamber analysis and histo-
logic examination. The contralateral vein was used
for the determination of local thrombogenicity
before harvest.
Thrombogenicity. One hundred milliliters of
blood was withdrawn from each animal and placed
in 14 mL of modified anticoagulant-citrate dextrose
solution (ACD Solution Modified; Squibb
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Diagnostics, New Brunswick, NJ). This was cen-
trifuged at 900 rpm for 20 minutes, and the platelet-
rich supernatant was collected and centrifuged at
2600 rpm for 10 minutes. All centrifugations were
done at 22°C. The plasma was decanted off, and the
platelet pellet was resuspended with ACD Solution
and centrifuged for 10 minutes at 2600 rpm. The
platelets were resuspended in the presence of indium
(In) 111 oxyquinoline (Amersham Corporation,
Arlington Heights, Ill) and incubated at room tem-
perature for 20 minutes. The platelets were washed
twice with ACD Solution (centrifuged at 2600 rpm
for 10 min) then in 5 mL of the previously decant-
ed plasma (centrifuged at 500 rpm for 5 min). The
supernatant was then injected into the animal.
Radioactive platelets were injected immediately after
labeling and allowed to circulate 3 hours before the
femoral vein was harvested. Freeze-dried human fi-
brinogen labeled with radioactive iodine (125I;
Amersham Corporation) was reconstituted in 1.1
mL ACD Solution and 1.9 µCi/kg was injected
immediately after the platelets.
At harvest, one femoral vein was cut into four
segments; the length and the width of each were
measured to calculate the surface area. Activity of
111In-platelets and 125I-fibrinogen was determined
for each venous segment with a two-channel gamma
counter (Packard Instruments, Downers Grove, Ill).
Whole blood samples obtained at the time of vein
harvest were assessed for 111In activity. Platelet con-
centration was determined with the use of a hemo-
cytometer. Platelet and fibrin deposition were then
calculated with the following formulas (see box
below).
Organ chamber studies. Contralateral femoral
vein was sectioned into 0.5-cm segments and
immersed in chilled Krebs-Ringer bicarbonate solu-
tion (NaCl 118.3 mmol/L, KCl 4.7 mmol/L,
CaCl2 2.5 mmol/L, MgSO4 1.2 mmol/L, KH2PO4
1.22 mmol/L, NaHCO3 25.0 mmol/L, glucose
11.1 mmol/L, CaEDTA 0.026 mmol/L). The
endothelium was deliberately removed from one half
of the rings by the gentle rubbing of the luminal sur-
face with fine forceps. Rings were suspended
between a fixed point and a force transducer (Soltec
8K40; Soltec Corporation, San Francisco, Calif) and
immersed in 25 mL Krebs-Ringer bicarbonate solu-
tion at 37°C with 95% oxygen and 5% carbon diox-
ide for 30 minutes to allow for equilibration. Rings
were placed at their optimal point in their length-
tension relationship, as determined by tension devel-
oped to contraction with norepinephrine (3.1 × 10–7
mmol) at varying degrees of stretch. Maximal con-
traction to norepinephrine (10–4 mmol) was deter-
mined for each ring. All rings were incubated with
indomethacin (10–5 mmol) to inhibit synthesis of
prostaglandins. A pair of rings, with and without
endothelium, was incubated with the L-arginine
analog NG-monomethyl-L-arginine (L-NMMA;
10–4 mmol) for 40 minutes before the first dose-
response experiments. Rings were washed and
allowed to return to baseline tension between dose-
response curves; L-NMMA and indomethacin were
readded before each dose-response curve.
For the study of relaxation, rings underwent
submaximal contraction with prostaglandin F2α
(PGF2α; 2 × 10–6 mmol). Responses to adenosine
diphosphate (ADP; 10–8-10–4 mmol) in rings with
and without endothelium, to nitric oxide (3 ×
10–9-10–5 mmol) in rings without endothelium,
and to calcium ionophore A23187 (10–9-10–6
mmol) in rings with endothelium were deter-
mined. Contractions to serotonin (10–10-10–5
mmol) over baseline tension were determined in
rings with and without endothelium. All drugs
were prepared daily in distilled water. Calcium
ionophore was dissolved in dimethyl sulfoxide and
diluted in distilled water. The final bath concentra-
tion of dimethyl sulfoxide was 8.2 × 10–3 mmol.
Nitric oxide was prepared as described by Palmer
et al.15 All concentrations are expressed as final
bath concentrations.
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Platelet deposition =  
Fibrin deposition =  
 
3.8  1011 ng fibrinogen

1 mmol fibrinogen
1 mmol

80 Ci
1 Ci

106 Ci
1 Ci

2,200,000 count
125I counts per cm2

0.54
platelet concentration

1 mL whole blood
1 mL whole blood
111In counts
111In counts per segment

cm2 segment
Histologic findings. One ring of the distal
femoral vein (5-mm length) was fixed in 10% forma-
lin and embedded in paraffin. The adjacent ring was
opened longitudinally and fixed in glutaraldehyde
(4%) for electron microscopy. Paraffin-embedded
sections were stained with hematoxylin and eosin or
elastica-van Gieson’s stain. Immunohistochemical
staining for α-smooth muscle cell actin and desmin
(DAKO Corporation, Carpinteria, Calif) was per-
formed as described by Shi et al.16 The presence of
organized, recanalized intraluminal thrombus was
assessed by two independent observers who were
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Fig 1. Color duplex ultrasound scan recording of femoral vein immediately after completion
of therapy for acute DVT with either urokinase for 90 minutes (A) or thrombectomy (B).
Turbulence of flow, indicated by the red area in the thrombectomized vein is consistent with
an area of retained thrombus.
A
B
blinded to the origin of the slides (J.M.R., R.R.).
Recanalized or organized thrombus was defined as
an increase in intimal thickness with evidence of
neovascularization between the internal elastic lami-
na and the venous lumen.17 The degree of endothe-
lial cell damage was assessed with scanning electron
microscopy and scored by an observer blinded to the
origin of the sections (G.M.). The following scale
was used for endothelial cell loss: 0% to 10% = 1;
11% to 25% = 2; 26% to 50% = 3; 51% to 75% = 4;
and 76% to 100% = 5.11
Statistical analysis. All data are expressed as
mean ± SEM. Differences in platelet and fibrin
deposition, maximal contractions, and relaxations
during organ chamber analysis were determined by
one-way analysis of variance, or t-test where appro-
priate. Post hoc analysis was performed with the
Student-Newman-Keuls test. Relaxations were
expressed as percent relaxation compared with peak
tension obtained with PGF2α contraction.
Contractions were expressed as percentage of maxi-
mal contraction obtained with norepinephrine (10–4
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Table I. Thrombogenicity of femoral veins 4 weeks after treatment
Group 1 Group 2 Group 3
Platelet deposition (platelets/cm2) 10,020 ± 4225 9560 ± 2653 6505 ± 1594
Fibrin deposition (ng/cm2) 3.4 ± 1.1 4.6 ± 1.2 6.1 ± 1.7
Limbs (n) 4 6 6
Differences were not statistically significant.
Fig 2. Light photomicrographs of cross sections (6 µm) through femoral veins 4 weeks after
treatment of acute DVT with either thrombectomy (A) or thrombolysis (B). Organized,
recanalized thrombus with capillary in-growth was observed only in segments of thrombec-
tomized veins. (Hematoxylin and eosin stain; original magnification, ×50.)
A B
mmol). For the dose-response curves, the area under
the curves was calculated for individual animals, and
then means were compared among groups.
Comparisons of valvular competence and the pres-
ence of recanalized thrombus were made with
Fisher’s exact test or chi-squared analysis. A P value
less than .05 was considered significant.
RESULTS
Thrombogenicity and valvular competence.
All ligated veins contained thrombus 48 hours after
ligation. Duplex ultrasound scanning confirmed the
complete clearing of luminal thrombus in all limbs
that were treated with thrombolysis (Fig 1, A).
Small areas of turbulence that were detected on
duplex scanning, consistent with retained thrombus,
were present in all thrombectomized limbs (Fig 1,
B). There was no significant luminal narrowing or
evidence of gross thrombus by B-mode or color
Doppler ultrasound scan that warranted repeat
thrombectomy. Four weeks after the treatment, all
veins were patent. Valvular incompetence (reflux
duration, >0.5 seconds) was seen in two of 12
thrombectomized limbs. Valves at or just above the
inguinal ligament were responsible for maintaining
competence in several of the thrombectomized ani-
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Fig 3. Light photomicrographs of immunohistochemical staining for α-smooth muscle cell actin and
desmin 4 weeks after treatment of acute DVT. Photomicrographs: urokinase treated, α-smooth 
muscle cell actin (A) and desmin (B), thrombectomized segment, α-smooth muscle cell actin
A
B
mals. All segments of sham-operated (n = 11) and
urokinase-treated veins (n = 11) had competent
valves. Thrombogenicity was similar among all
groups (Table I).
Histologic findings. The presence of recanal-
ized, organized thrombus was significantly greater in
the thrombectomized group (group 3, four of six
animals) than either the thrombolysis (group 2, one
of six animals) or sham-operated groups (group 1,
none of five animals; P = .04; Fig 2). The veins treat-
ed with thrombolysis demonstrated positive staining
for both α-smooth muscle cell actin and desmin in
the media without evidence of intimal proliferation
(Fig 3, A and B; the location of internal elastic lam-
ina confirmed on elastica-van Gieson’s sections, not
shown). Thrombectomized veins demonstrated pos-
itive staining for α-smooth muscle cell actin both in
the media and in areas of recanalization (Fig 3, C).
Desmin staining, present in the media, was absent in
areas of recanalization (Fig 3, D). Both the luminal
surface and the capillaries within the recanalized
areas appeared to have an endothelial cell covering.
Staining for von Willibrand’s Factor was not per-
formed because of the known variability of staining
in canines.18,19 Scanning electron microscopy
demonstrated similar degrees of endothelial cell loss
in all groups (group 1, 1.6 ± 0.4; group 2, 2.4 ± 0.5;
group 3, 2.0 ± 0.0), with an average loss of approx-
imately 25% (Fig 4).
Organ chamber analysis. Maximal contractions
to norepinephrine (10–4 mmol) and PGF2α (2 ×
10–6 mmol) were similar among groups. Mean max-
imal contractions to norepinephrine (10–4 mmol)
ranged from 5.1 ± 1.4 g to 6.6 ± 1.8 g in all groups,
with and without endothelium. ADP caused con-
centration-dependent relaxations in all rings, with
and without endothelium, in all groups. Inhibition
of nitric oxide synthesis with L-NMMA shifted this
response significantly to the right in rings containing
endothelium from the sham and thrombolyzed
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Fig 3 Cont’d. (C) and desmin (D). Smooth muscle cells stain with both α-smooth muscle cell actin
and desmin; myofibroblasts stain with α-smooth muscle cell actin only. The media from the thrombec-
tomized vessel is out of view; all staining is within the recanalized thrombus. The vessel that was treat-
ed by thrombolysis stains for both α-smooth muscle cell actin and desmin within the media. These are
high-power views (original magnification, ×200) of the same segments as in Fig 2.
C D
groups, but not the thrombectomized group (Fig
5). After PGF2α contraction, calcium ionophore
A23187 caused concentration-dependent relax-
ations in rings with endothelium in all groups.
Relaxations in groups 1 and 2 were not altered by 
L-NMMA; however, relaxations in group 3
(thrombectomized segments) were significantly
inhibited by L-NMMA (P < .05 for both groups 1
and 2 vs group 3; Fig 6). Relaxations to exogenous
nitric oxide were similar among groups and were not
altered by inhibition of endogenous nitric oxide
with L-NMMA (Fig 7).
Serotonin caused dose-dependent contractions
in rings, with and without endothelium, over the
dosage range from 10–10 to 10–7 mmol. These con-
tractions were similar in all groups and not altered
by L-NMMA. At concentrations of serotonin
greater than 10–7 mmol, all rings relaxed in a dose-
dependent fashion. Relaxations were inhibited by L-
NMMA only in thrombectomized rings that had
been denuded of luminal endothelial cells (P = .02;
Fig 8).
DISCUSSION
A growing body of clinical evidence supports the
idea that early resolution of a thrombus after acute
DVT is associated with improved outcome.5-7 This
may be achieved by early spontaneous lysis, by
mechanical removal of the thrombus, or by infusion
of thrombolytic agents. With standard therapy
alone, a significant number of patients will manifest
some degree of the postthrombotic syndrome after
an episode of acute DVT, with its incipient life-long
clinical consequences and costs of therapy.2-4 The
presently available means to expedite early thrombus
clearance from an involved segment include venous
thrombectomy or catheter-directed thrombolytic
therapy. The present study addressed the effects of
these therapies on venous structure and function.
Four weeks after the treatment of acute DVT in
canines, both thrombectomy and urokinase treat-
ment restored venous patency, demonstrated by
unobstructed flow on duplex ultrasound scanning.
However, 66% of thrombectomized veins demon-
strated histologic evidence of intimal thickening that
was associated with capillary ingrowth and myofi-
broblast expression. This had the appearance of
organized and recanalized thrombus and is consis-
tent with previous reports.17 The origin of the
recanalized thrombus is most likely a combination of
incomplete clearing of the original thrombus and
propagation or rethrombosis after thrombectomy.
Duplex scanning provided evidence that a single pas-
sage of the catheter adequately cleared the throm-
bosed vein. Repeated passages of the Fogarty
catheter were not performed because it was felt that
the amount of thrombus remaining was minimal and
that additional passages would have resulted in fur-
ther mechanical trauma.20,21 However, thrombolysis
resulted in complete clearing of thrombus, which
was associated with a significantly lower incidence of
recanalized thrombus 4 weeks after therapy.
Our initial study demonstrated a twofold increase
in platelet deposition immediately after thrombecto-
my when compared with sham- and urokinase-treat-
ed segments.12 At 4 weeks, all groups had similar
thrombogenicity, as measured by radiolabeled
platelet and fibrin deposition. In addition, the levels
of platelet and fibrin deposition at 4 weeks were com-
parable to the sham levels immediately after therapy
(day 0). This is likely related to the significant degree
of reendothelialization at 4 weeks. The presence of
recanalized, reendothelialized thrombus does not
appear to increase the local thrombogenicity; howev-
er, the sensitivity of this assay with in vivo circulation
of radiolabeled products may not be adequate to
detect subtle differences.
Valvular incompetence has previously been
shown to occur predominantly in venous segments
that were initially involved with thrombus and that
valvular competence is adversely affected by
rethrombosis.22-24 In the present study, 4 weeks
after treatment, 17% of thrombectomized limbs
demonstrated reflux. Venous segments with reflux
had histologic evidence of organized, recanalized
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Fig 4. Scanning electron photomicrographs of a represen-
tative segment of femoral vein after urokinase treatment of
deep vein thrombosis. Grade 2 (11%-25%) endothelial cell
loss is depicted. Most segments, regardless of treatment
modality, demonstrated grade 2 endothelial cell loss at 4
weeks after treatment. (Original magnification, ×1000.)
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Fig 5. Concentration-response curves to ADP in segments of femoral vein with endothelium in the pres-
ence or absence of the nitric oxide synthase inhibitor L-NMMA, 4 weeks after treatment of acute DVT
in sham-operated (A), thrombolysis-treated (B), or thrombectomized veins (C). Data are shown as mean
± SEM and are expressed as percent relaxation after a submaximal contraction with PGF2α (2 × 10–6
mmol). L-NMMA significantly inhibited relaxations in sham-operated and thrombolysis-treated rings;
asterisk (*) denotes significant shift to the right (P = .02). Relaxations in thrombectomy-treated veins
were not inhibited by L-NMMA.
Fig 6. Concentration-response curves to calcium ionophore A23187 in segments of femoral vein 4
weeks after treatment for acute DVT. All rings contained endothelium, and all curves were performed
in the presence of L-NMMA. Group 3 (thrombectomized) segments relaxed significantly less than
either group 1 (sham-operated) or group 2 (thrombolysis-treated) vessels. (*P < .05 for both group 1
and 2 vs group 3 by analysis of variance). Data are shown as mean ± SEM and are expressed as percent
relaxation after a submaximal contraction with PGF2α (2 × 10–6 mmol).
A B
C
thrombus. Even though the number of thrombec-
tomized limbs that demonstrated reflux was not
great enough to reach statistical significance, this
trend may be clinically relevant for two reasons.
First, several limbs that were treated with thrombec-
tomy had competent valves at or just proximal to the
inguinal ligament. These valves were able to prevent
reflux despite apparent incompetence of the com-
mon and superficial femoral veins. Limbs treated
with thrombolysis all had competent valves within
the femoral vein. Second, reflux is known to devel-
op over time. Markel et al24 documented reflux in
13% of common femoral and 20% of superficial
femoral veins 1 month after an episode of acute
DVT. At 3 years, 46% and 29% of these segments
demonstrated reflux, respectively. With a longer
duration of follow-up, we hypothesize that the trend
of greater reflux in thrombectomized limbs would
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Fig 7. Concentration-response curves to nitric oxide (NO) in segments of femoral vein with-
out endothelium 4 weeks after treatment for acute DVT. All rings relaxed in response to nitric
oxide, and there were no differences between groups. Data are shown as mean ± SEM and are
expressed as percent relaxation after a submaximal contraction with PGF2α (2 × 10–6 mmol).
Fig 8. Concentration-response curves to serotonin in segments of femoral vein without lumi-
nal endothelial cells, in the presence or absence of L-NMMA, 4 weeks after thrombectomy for
the treatment of acute DVT. There is a significant inhibition to relaxation by L-NMMA at
serotonin doses of more than 10–7 mmol; asterisk (*) denotes significant shift to the right (P
= .02) Data are shown as mean ± SEM and are expressed as percent of change in tension com-
pared with a maximal contraction with norepinephrine (10–4 mmol).
have continued, given the associated histologic find-
ings. The lack of residual or recurrent thrombus
within veins treated with thrombolytics would make
the development of reflux less likely because valve
architecture would be preserved, although reflux is
known to develop even in segments uninvolved with
thrombus.25 In addition to the histologic and hemo-
dynamic differences seen among the treatment
groups, a functional difference was identified. These
functional differences are important because nitric
oxide inhibits thrombogenicity and cell prolifera-
tion.13,14 The maintenance of nitric oxide–mediated
vasoreactive pathways would limit both late
rethrombosis and neointimal proliferation. The
mechanism of relaxation to ADP in sham-operated
and urokinase-treated limbs is in part nitric oxide
mediated. This is evidenced by the inhibition of
relaxations in the presence of the nitric oxide syn-
thase inhibitor L-NMMA. Relaxations to ADP in
thrombectomized segments are nitric oxide inde-
pendent. Because these experiments were performed
in the presence of indomethacin, prostanoids can be
excluded as the mediator of ADP-stimulated relax-
ations in these vessels. It is possible that other relax-
ing factors such as C-type natriuretic peptide,
adrenomedullin, endothelial hyperpolarizing factor,
or a yet unspecified mediator is responsible for these
relaxations.26-28 Normal venous endothelium pro-
duces relaxation in the presence of calcium
ionophore A23187. This relaxation is not inhibited
by L-NMMA in veins, as opposed to the response in
arteries.29 Thrombectomized veins did relax in the
presence of calcium ionophore, however this was in
part inhibited by L-NMMA. Urokinase-treated ves-
sels responded in a similar fashion as sham-operated
vessels, both relaxing to calcium ionophore through
a nitric oxide and prostanoid independent pathway.
Four weeks after treatment, smooth muscle cell
function was similar among groups, as assessed by
the ability of nitric oxide to relax rings without
endothelium after contraction with PGF2α. This is in
contrast to earlier data that demonstrated thrombec-
tomy decreased smooth muscle cell response to
nitric oxide when examined at the time of initial
treatment.12 Venous smooth muscle cells recover the
ability to respond to nitric oxide–mediated relax-
ation by 4 weeks after treatment.
The difference in relaxations to ADP and calci-
um ionophore in thrombectomized vessels demon-
strates that the endothelium of thrombectomized
vessels is phenotypically different than that of sham-
or urokinase-treated vessels. The scanning electron
microscope data confirm that this finding is not a
result of differential endothelial cell loss, because all
groups had a similar degree of cell loss (less than
25%). The relative contributions of the luminal
endothelial cells compared with those endothelial
cells within the recanalized areas remain unknown.
Because this finding was unexpected, experiments
were not specifically designed to detect these differ-
ences. However, the response of these vessels to
serotonin demonstrates that the endothelium within
the recanalized areas may contribute to the overall
vasoreactivity of the vessel by way of a nitric
oxide–mediated pathway. L-NMMA inhibited relax-
ations at high serotonin concentrations in
thrombectomized segments that had been denuded
of luminal endothelial cells. Because the endotheli-
um within the recanalized area is inaccessible to
mechanical removal, these endothelial cells are a
potential source of serotonin-mediated nitric oxide
release. This response to nitric oxide inhibition was
not seen in sham-operated or thrombolyzed veins.
This type of nitric oxide–dependent relaxation to
serotonin has been seen in canine renal arteries.30 It
is possible that the endothelium in the recanalized
areas represents a phenotypic variant of venous
endothelium or may even have a nonvenous origin.
An alternative explanation may be that macrophages
present in this thrombus are releasing the vasoactive
substances; however, white cell infiltrates were not
appreciated on histologic examination.
The long-term effects of the functional changes
that we have described remain unknown. The fact
that the thrombolysis and sham-operated animals
responded similarly suggests that long-term function
will also be preserved after thrombolysis. Usui et al17
demonstrated that, 4 weeks after venous thrombosis
in canines, histologic organization or recanalization
of the thrombus is complete. If one assumes that
physiologic “organization” is also complete, then
these functional differences seen at 4 weeks in the
thrombectomized veins would be expected to persist
over time. These histologic changes are not the same
as observed in intimal hyperplasia of vein grafts or
after balloon injury to arteries.31,32
In clinical practice, some authors advocate the
routine use of an arteriovenous fistula as an adjunctive
measure to venous thrombectomy.9,10 This is left in
place for about 6 weeks after thrombectomy. The
purpose of this fistula is to provide high flow through
the thrombectomized segment until the denuded
endothelium can be regenerated, thus minimizing the
risk of early rethrombosis. Einarsson et al33 demon-
strated that reendothelialization occurs by 4 weeks
after thrombectomy in dogs when an arteriovenous
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fistula is used in conjunction. This correlates well with
our scanning electron microscope data. They also
noted that, even after 4 months, the endothelium at
the site of the fistula was still denuded because of the
“. . . continuous injury to the endothelium from the
turbulent arterial blood flow . . .”33 Alterations in
blood flow, including the use of a fistula, have been
shown to effect both the structure and vasoreactive
responses of both arteries and veins.31,34 To avoid the
potential histologic and physiologic changes associat-
ed with the arteriovenous fistula rather than the actu-
al thrombectomy, we did not include it as part of the
present protocol. The specific functional effects of the
fistula in conjunction with venous thrombectomy will
also require further investigation.
The differences seen between thrombectomy and
thrombolysis in this study appear to be related to the
presence of organized, recanalized thrombus. We have
demonstrated that this recanalized thrombus is func-
tionally active and has some vasoreactive properties
that are distinct from both control veins and those
treated with thrombolysis. Although recanalization
with biologically active endothelial cells capable of
nitric oxide production has theoretic benefits, both the
natural history studies of DVT and our experimental
findings on duplex ultrasound scanning indicate that
this may be inadequate to prevent the progression of
valvular incompetence and venous hemodynamic
derangement. Thrombolysis for the treatment of acute
DVT in our model maintained valvular competence at
1 month and preserved physiologic venous vasoreac-
tivity compared with sham-operated controls.
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